Pharmacy Consulting

Pharmacy Healthcare Solutions LLC (PHSL) consults with pharmaceutical manufacturers, PBMs, pharmacies (retail, specialty, mail service, LTC, and hospital outpatient), and technology companies on strategic business and marketing issues. Consulting projects across these market segments provide PHSL with the latest information on emerging trends as well as new products and services. Our consultants have extensive retail, mail service and managed care experience to create actionable recommendations for our clients’ challenging business issues.

Learn More About PHSL Services

News & Events

Pharmacy Technology & Management Review March/April 2024

PHSL President Ann Johnson and University of Pittsburgh Pharm.D. Candidate Sydney Stawarz contributed to the March/April 2024 edition of Pharmacy Technology & Management Review (PTMR). In their Viewpoints article, Ann and Sydney discuss the risks of using ChatGPT for medication information and provide alternative, reliable sources that pharmacists can utilize and recommend to their patients.  Click Read More →

PHSL to Attend NCPDP’s May Work Group Meetings and Annual Conference

PHSL Senior Consultants Dave Schuetz and Patty Milazzo and PHSL Consultant Alan Sekula will be attending the National Council for Prescription Drug Programs (NCPDP) Joint Technical Work Group Meetings and Annual Technology & Business Conference on May 5-8, 2024 at the Westin Kierland in Scottsdale, AZ.  The Work Group Meetings provide a venue for NCPDP Read More →

NCPDP recognized PHSL Senior Consultant Dave Schuetz

Congratulations to PHSL Senior Consultant Dave Schuetz for being recognized by NCPDP as Most Valuable Participant (MVP) for dedication as a task group leader for the WG2 Product Review and Billing Unit Exception Task Group at the February 2024 Work Group meeting.  Thanks for all of your efforts and leadership!   Posted: February 2024

Latest from the Blog

Manufacturers to Voluntarily Cap Prices on Numerous Inhalers

Three of the four major inhaler manufacturers in the United States have announced the implementation of an inhaler price cap, which is set to take effect this year. Many inhalers have high costs, with uninsured or high-deductible health plan (HDHP) patients often paying $200 to $600 for a one-month supply. However, the price of inhalers Read More →

OTC Oral Contraceptive Coming in 2024

Oral contraceptives are a safe, affordable, and effective way of preventing pregnancy. In July 2023, the FDA approved Opill (norgestrel) tablet, the first daily oral contraceptive that will be available for sale in the United States without a prescription. Opill is a new option for individuals who do not have access to a physician and Read More →

Gene Therapy Challenges and Compendia Implications

Gene therapy is an emerging topic in the medical field with new innovations and successes documented daily. The FDA shared their prediction that, based on the current pipeline, they expect to approve anywhere from 10-20 gene and cellular therapy products each year beginning in 2025. Gene therapy works by replacing a disease-causing gene, inactivating genes Read More →